$116.55
0[0.00%]
At close: Apr 18
$116.55
0[0.00%]
PreMarket: 4:20PM EDT
Sarepta Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sarepta Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/30/2024 | PM | SRPT | Q1 | -$0.97 | -$0.05 | — | — | $253.50M | $376.16M | — | — | Get Alert |
02/28/2024 | PM | SRPT | Q4 | -$0.53 | $0.01 | $0.82 | 8100.00% | $258.43M | $385.81M | $396.78M | 2.84% | Get Alert |
11/01/2023 | PM | SRPT | Q3 | -$0.80 | -$1.32 | $0.37 | 128.03% | $230.27M | $288.50M | $331.82M | 15.01% | Get Alert |
08/02/2023 | PM | SRPT | Q2 | -$1.18 | -$1.89 | -$0.85 | 55.03% | $233.49M | $264.45M | $261.24M | -1.21% | Get Alert |
05/02/2023 | PM | SRPT | Q1 | -$0.56 | -$1.38 | -$0.97 | 29.71% | $210.83M | $241.96M | $253.50M | 4.77% | Get Alert |
02/28/2023 | PM | SRPT | Q4 | -$0.77 | -$1.35 | -$0.53 | 60.74% | $201.46M | $248.34M | $258.43M | 4.06% | Get Alert |
11/02/2022 | PM | SRPT | Q3 | -$0.19 | -$1.43 | -$0.80 | 44.06% | $189.41M | $234.52M | $230.27M | -1.81% | Get Alert |
08/02/2022 | PM | SRPT | Q2 | -$1.52 | -$1.18 | -$1.18 | 0.00% | $164.09M | $220.81M | $233.49M | 5.74% | Get Alert |
05/04/2022 | PM | SRPT | Q1 | -$1.54 | -$1.27 | -$0.56 | 55.91% | $146.93M | $206.44M | $210.83M | 2.13% | Get Alert |
03/01/2022 | PM | SRPT | Q4 | -$1.84 | -$1.13 | -$0.77 | 31.86% | $145.14M | $198.61M | $201.46M | 1.44% | Get Alert |
11/03/2021 | PM | SRPT | Q3 | -$1.42 | -$1.89 | -$0.19 | 89.95% | $143.92M | $173.42M | $189.41M | 9.22% | Get Alert |
08/04/2021 | PM | SRPT | Q2 | -$1.51 | -$1.29 | -$1.52 | -17.83% | $137.36M | $162.64M | $164.09M | 0.89% | Get Alert |
05/05/2021 | PM | SRPT | Q1 | -$1.04 | -$1.78 | -$1.54 | 13.48% | $113.67M | $143.33M | $146.93M | 2.51% | Get Alert |
03/01/2021 | PM | SRPT | Q4 | -$1.57 | -$1.77 | -$1.84 | -3.95% | $100.11M | $146.29M | $145.14M | -0.79% | Get Alert |
11/05/2020 | PM | SRPT | Q3 | -$1.14 | -$1.71 | -$1.42 | 16.96% | $99.04M | $137.43M | $143.92M | 4.73% | Get Alert |
08/05/2020 | PM | SRPT | Q2 | -$0.83 | -$1.72 | -$1.51 | 12.21% | $94.67M | $118.78M | $137.36M | 15.64% | Get Alert |
05/06/2020 | PM | SRPT | Q1 | -$0.75 | -$1.78 | -$1.04 | 41.57% | $87.01M | $119.15M | $113.67M | -4.60% | Get Alert |
02/26/2020 | PM | SRPT | Q4 | -$0.85 | -$1.86 | -$1.57 | 15.59% | $84.42M | $98.85M | $100.11M | 1.28% | Get Alert |
11/07/2019 | PM | SRPT | Q3 | -$0.56 | -$1.36 | -$1.14 | 16.18% | $78.49M | $96.99M | $99.04M | 2.11% | Get Alert |
Sarepta Therapeutics (SRPT) is scheduled to report earnings on April 30, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $0.82, which beat the estimate of $0.01.
The Actual Revenue was $396.8M, which beat the estimate of $385.8M.
Browse earnings estimates, EPS, and revenue on all stocks.